Ticker: BBIO

Company: BridgeBio Pharma, Inc.

Person: Neil Kumar, director, officer

Transaction date: April 22, 2025

Reporting date: April 24, 2025

Average share price: 34.107

Sold 75000.0 shares for 2558025.0